Literature DB >> 18817931

Biomarkers of environmental toxicity and susceptibility in autism.

David A Geier1, Janet K Kern, Carolyn R Garver, James B Adams, Tapan Audhya, Robert Nataf, Mark R Geier.   

Abstract

Autism spectrum disorders (ASDs) may result from a combination of genetic/biochemical susceptibilities in the form of a reduced ability to excrete mercury and/or increased environmental exposure at key developmental times. Urinary porphyrins and transsulfuration metabolites in participants diagnosed with an ASD were examined. A prospective, blinded study was undertaken to evaluate a cohort of 28 participants with an ASD diagnosis for Childhood Autism Rating Scale (CARS) scores, urinary porphyrins, and transsulfuration metabolites. Testing was conducted using Vitamin Diagnostics, Inc. (CLIA-approved) and Laboratoire Philippe Auguste (ISO-approved). Participants with severe ASDs had significantly increased mercury intoxication-associated urinary porphyrins (pentacarboxyporphyrin, precoproporphyrin, and coproporphyrin) in comparison to participants with mild ASDs, whereas other urinary porphyrins were similar in both groups. Significantly decreased plasma levels of reduced glutathione (GSH), cysteine, and sulfate were observed among study participants relative to controls. In contrast, study participants had significantly increased plasma oxidized glutathione (GSSG) relative to controls. Mercury intoxication-associated urinary porphyrins were significantly correlated with increasing CARS scores and GSSG levels, whereas other urinary porphyrins did not show these relationships. The urinary porphyrin and CARS score correlations observed among study participants suggest that mercury intoxication is significantly associated with autistic symptoms. The transsulfuration abnormalities observed among study participants indicate that mercury intoxication was associated with increased oxidative stress and decreased detoxification capacity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18817931     DOI: 10.1016/j.jns.2008.08.021

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  46 in total

1.  Liposomal-glutathione provides maintenance of intracellular glutathione and neuroprotection in mesencephalic neuronal cells.

Authors:  Gail D Zeevalk; Laura P Bernard; F T Guilford
Journal:  Neurochem Res       Date:  2010-06-10       Impact factor: 3.996

2.  A protein switch sensing system for the quantification of sulfate.

Authors:  Krystal Teasley Hamorsky; Charles Mark Ensor; Patrizia Pasini; Sylvia Daunert
Journal:  Anal Biochem       Date:  2011-10-18       Impact factor: 3.365

3.  Mercury induces inflammatory mediator release from human mast cells.

Authors:  Duraisamy Kempuraj; Shahrzad Asadi; Bodi Zhang; Akrivi Manola; Jennifer Hogan; Erika Peterson; Theoharis C Theoharides
Journal:  J Neuroinflammation       Date:  2010-03-11       Impact factor: 8.322

Review 4.  Environmental factors associated with autism spectrum disorder: a scoping review for the years 2003-2013.

Authors:  M Ng; J G de Montigny; M Ofner; M T Do
Journal:  Health Promot Chronic Dis Prev Can       Date:  2017-01       Impact factor: 3.240

5.  Altered urinary porphyrins and mercury exposure as biomarkers for autism severity in Egyptian children with autism spectrum disorder.

Authors:  Eman M Khaled; Nagwa A Meguid; Geir Bjørklund; Amr Gouda; Mohamed H Bahary; Adel Hashish; Nermin M Sallam; Salvatore Chirumbolo; Mona A El-Bana
Journal:  Metab Brain Dis       Date:  2016-07-13       Impact factor: 3.584

6.  Heavy metals and trace elements in hair and urine of a sample of arab children with autistic spectrum disorder.

Authors:  Eleonor Blaurock-Busch; Omnia R Amin; Thanaa Rabah
Journal:  Maedica (Buchar)       Date:  2011-10

Review 7.  Chemical and molecular mechanisms of antioxidants: experimental approaches and model systems.

Authors:  Jian-Ming Lü; Peter H Lin; Qizhi Yao; Changyi Chen
Journal:  J Cell Mol Med       Date:  2009-09-14       Impact factor: 5.310

8.  Hyperbaric treatment for children with autism: a multicenter, randomized, double-blind, controlled trial.

Authors:  Daniel A Rossignol; Lanier W Rossignol; Scott Smith; Cindy Schneider; Sally Logerquist; Anju Usman; Jim Neubrander; Eric M Madren; Gregg Hintz; Barry Grushkin; Elizabeth A Mumper
Journal:  BMC Pediatr       Date:  2009-03-13       Impact factor: 2.125

9.  The severity of autism is associated with toxic metal body burden and red blood cell glutathione levels.

Authors:  J B Adams; M Baral; E Geis; J Mitchell; J Ingram; A Hensley; I Zappia; S Newmark; E Gehn; R A Rubin; K Mitchell; J Bradstreet; J M El-Dahr
Journal:  J Toxicol       Date:  2009-08-26

10.  Safety and efficacy of oral DMSA therapy for children with autism spectrum disorders: Part A--medical results.

Authors:  James B Adams; Matthew Baral; Elizabeth Geis; Jessica Mitchell; Julie Ingram; Andrea Hensley; Irene Zappia; Sanford Newmark; Eva Gehn; Robert A Rubin; Ken Mitchell; Jeff Bradstreet; Jane El-Dahr
Journal:  BMC Clin Pharmacol       Date:  2009-10-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.